We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
-6.45%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$440M
AUM Growth
+$68.3M
Cap. Flow
+$121M
Cap. Flow %
27.55%
Top 10 Hldgs %
7.16%
Holding
1,009
New
355
Increased
190
Reduced
143
Closed
321

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$7.33M
2
AZN icon
AstraZeneca
AZN
+$3.83M
3
SPB icon
Spectrum Brands
SPB
+$3.54M
4
BNS icon
Scotiabank
BNS
+$3.5M
5
TSN icon
Tyson Foods
TSN
+$3.37M

Top Sells

Rank Stock Value
1
VIRT icon
Virtu Financial
VIRT
+$3.48M
2
DOV icon
Dover
DOV
+$2.95M
3
TU icon
Telus
TU
+$2.82M
4
SYK icon
Stryker
SYK
+$2.58M
5
TTWO icon
Take-Two Interactive
TTWO
+$2.49M

Sector Composition

Rank Sector Weight
1 Healthcare 18.71%
2 Technology 17.25%
3 Industrials 13.57%
4 Financials 13.31%
5 Consumer Discretionary 12.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORA icon
401
Ormat Technologies
ORA
$6.98B
$380K 0.09%
+4,406
New +$392K
WABC icon
402
Westamerica Bancorp
WABC
$1.39B
$380K 0.09%
+7,265
New +$414K
PFE icon
403
Pfizer
PFE
$153B
$379K 0.09%
+8,659
New +$421K
BMRN icon
404
BioMarin Pharmaceuticals
BMRN
$13.3B
$377K 0.09%
4,450
-7,275
-62% -$648K
EXAS
405
DELISTED
Exact Sciences
EXAS
$376K 0.09%
11,567
+2,385
+26% +$98.3K
ASX icon
406
ASE Group
ASX
$103B
$374K 0.09%
74,850
-59,477
-44% -$335K
SNPS icon
407
Synopsys
SNPS
$78.8B
$374K 0.09%
+1,225
New +$415K
PRKS icon
408
United Parks & Resorts
PRKS
$2.04B
$373K 0.08%
8,190
-569
-6% -$28.3K
EXEL icon
409
Exelixis
EXEL
$12.5B
$372K 0.08%
+23,752
New +$459K
LOPE icon
410
Grand Canyon Education
LOPE
$3.79B
$372K 0.08%
4,521
-3,377
-43% -$293K
GMAB icon
411
Genmab
GMAB
$19.3B
$371K 0.08%
11,560
-4,416
-28% -$155K
SCCO icon
412
Southern Copper
SCCO
$158B
$371K 0.08%
+9,032
New +$395K
DIOD icon
413
Diodes
DIOD
$4.48B
$370K 0.08%
5,706
-768
-12% -$55.5K
CATY icon
414
Cathay General Bancorp
CATY
$4.31B
$369K 0.08%
9,607
+2,294
+31% +$95.4K
IBCP icon
415
Independent Bank Corp
IBCP
$854M
$369K 0.08%
+19,325
New +$392K
GLDD
416
DELISTED
Great Lakes Dredge & Dock
GLDD
$367K 0.08%
+48,435
New +$507K
SF
417
Stifel
SF
$12.9B
$367K 0.08%
+10,599
New +$417K
FDS icon
418
Factset
FDS
$10.2B
$366K 0.08%
915
+237
+35% +$100K
NBTB icon
419
NBT Bancorp
NBTB
$2.79B
$366K 0.08%
+9,640
New +$381K
CIGI icon
420
Colliers International
CIGI
$5.41B
$364K 0.08%
3,976
+47
+1% +$5.48K
OZK icon
421
Bank OZK
OZK
$5.7B
$364K 0.08%
+9,193
New +$370K
RELX icon
422
RELX
RELX
$60.4B
$364K 0.08%
+14,962
New +$406K
DCOM icon
423
Dime Commercial Bancshares
DCOM
$1.82B
$363K 0.08%
+12,410
New +$395K
STRL icon
424
Sterling Infrastructure
STRL
$16.9B
$360K 0.08%
+16,759
New +$403K
TGI
425
DELISTED
Triumph Group
TGI
$360K 0.08%
41,952
-13,611
-24% -$178K
15 16
17
18 19

Similar funds

BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.9B AUM 2.22% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Campbell & Co Investment Adviser's Q3 2022 Portfolio in Review

As of Q3 2022, Campbell & Co Investment Adviser held 1,009 positions worth $440M, up 18% from $372M the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

Campbell & Co Investment Adviser deployed $121M of net new capital in Q3 2022, opening 355 new positions and adding to 190 existing holdings. Its largest new stake was GSK: 193,518 shares worth $5.7M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Dover, an estimated $2.95M trimmed.

  • Campbell & Co Investment Adviser's largest Q3 2022 buy was GSK: 193,518 shares worth $5.7M.
  • Campbell & Co Investment Adviser added most to Scotiabank in Q3 2022, an estimated $3.5M increase.
  • Campbell & Co Investment Adviser's biggest Q3 2022 reduction was Dover, cutting an estimated $2.95M.
  • Campbell & Co Investment Adviser fully exited Virtu Financial in Q3 2022, selling an estimated $3.48M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 7.2% of its $440M portfolio in Q3 2022.
  • Campbell & Co Investment Adviser opened 355 new positions and closed 321 in Q3 2022.
  • Campbell & Co Investment Adviser's portfolio value rose 18% quarter-over-quarter to $440M.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2022, filed 14 Nov 2022.